Skip to main content
. 2017 Sep 11;15(9):e04718. doi: 10.2903/j.efsa.2017.4718

Table 53.

Summary of literature reports of urinary DON/DON‐glucuronides/DOM‐1 biomarker data using the single biomarker method (DON expressed as ng DON/mL urine or ng DON/mg creatinine) (ordered by publishing year)

Population Number of subjects (F/M) Age (year) Positive samples (%) Total DON Mean (range) ± standard deviation (ng/mL) Total DON Mean (range) ± standard deviation (ng/mg) Analytical method (LOD/LOQ, ng/mL) Reference
UK 202 (128/74) 3–> 65 DON: 93 31.4, median: 19.3 DON (0.12/0.25) Brera et al. (2015)
DOM‐1: 0 DOM‐1 (0.25/0.5)
Italy 203 (122/81) DON: 76 9.12, median: 6.54 DON (0.25/0.5)
DOM‐1: 1.5 DOM‐1 (0.25/0.5)
Norway 230 (138/92) DON: 97 8.29, median: 6.12 DON (0.005/0.015)
DOM‐1: 12 DOM‐1 (0.09/0.27)
UK 15 (7/8) 22–50 DON: 100 (Year 1) 7.1 ± 8.0 DON (n.r./0.1) Gratz et al. (2014)
DON: 100 (Year 2) 13.5 ± 12.0
Sweden 326 (n.r.) 18–80 DON: 90 Median: 2.9 (< LOD–65.8) DON (0.25/0.5) Wallin et al. (2013)
UK 5 (3/2) n.r. DON: 100 3.62 (0.38–10.05) DON (0.1/n.r.) Gratz et al. (2013)
UK 85 (85/0) 16–44 DON: 100 10.3 (0.5–116.7)a DON (0.25/0.5) Hepworth et al. (2012)
DOM‐1: 0 DOM‐1 (LOQ = 0.06)
UK(b) 34 (16/18) Adults DON: 100 17.8 (5–78.2), median: 3.8 DON (0.25/0.5) Turner et al. (2011a)
DOM‐1: 0.3 0.65 (one sample) DOM‐1 (LOQ = 0.06)
UK 35 (18/18) 21–59 DON: 94 11.6 (< LOD–78.2) 10.1 (< LOD–70.7)a DON (0.5/n.r.) Turner et al. (2010a)
France 76 (0/76) 23–74 DON: 99 Median: 6.8 (0.5–28.8) DON (0.5/n.r.) Turner et al. (2010b)
DOM‐1: 34 0.2 (0.2–2.8) (positive samples) DOM‐1(LOD = 0.05)
UK 300 (158/142) 19–64 DON: 99 7.2 (6.2–8.2)a (L)9.2 (8.1–10.5)a (M)10.9 (9.5–12.4)a (H) DON (0.1/0.6) Turner et al. (2008a)
UK 25 (16/9) 21–59 DON: 100 10.7 (2.4–67.8)a 7.2 (4.9–10.5)a DON (n.r./0.6) Turner et al. (2008b)

n.r.: not reported; F: female; M: male; LOD: limit of detection; LOQ: limit of quantification; L: low dietary exposure; M: medium dietary exposure; H: high dietary exposure.

All urine samples were treated with enzymatic hydrolysis followed by IAC extraction prior to determination by HPLC‐MS.

a

geometric mean (95% CI); (b): all are selected positive samples from another study.